Basit öğe kaydını göster

dc.contributor.authorElemek, Eser
dc.contributor.authorAyan, Faruk
dc.contributor.authorMalali, Ezgi
dc.contributor.authorNoyan, Ulku
dc.contributor.authorEmekli, Nesrin
dc.contributor.authorBasar, Isik
dc.contributor.authorKoldas, Lale
dc.contributor.authorOKTAY, NİHAL ŞEHKAR
dc.contributor.authorALTURFAN, EBRU IŞIK
dc.date.accessioned2021-03-05T15:36:01Z
dc.date.available2021-03-05T15:36:01Z
dc.identifier.citationOKTAY N. Ş. , Basar I., ALTURFAN E. I. , Malali E., Elemek E., Ayan F., Koldas L., Noyan U., Emekli N., "Serum and saliva sialic acid in periodontitis patients with and without cardiovascular disease", Pathophysiology of Haemostasis and Thrombosis, cilt.37, ss.67-71, 2009
dc.identifier.issn1424-8832
dc.identifier.othervv_1032021
dc.identifier.otherav_bc919cd3-38a0-41dd-a827-10812217e60c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/125337
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79957965972&origin=inward
dc.identifier.urihttps://doi.org/10.1159/000321377
dc.description.abstractSerum total sialic acid (sTSA) has recently been shown to be a cardiovascular risk factor. However, there is little information about the role of sTSA and TSA in saliva in periodontitis, a chronic and inflammatory disease known to be a risk factor for cardiovascular disease (CVD). We aimed to investigate the changes in sTSA and TSA levels in saliva in patients having both periodontitis and CVD versus periodontitis patients without diagnosed CVD. The study group consisted of 26 patients with proven periodontitis and 26 controls with no diagnosed systemic disease but periodontitis. sTSA and saliva TSA levels were determined by the thiobarbituric acid method, and C-reactive protein (CRP) was evaluated by the nephelometric method. The severity of periodontitis has been determined by the community periodontal index of treatment needs (CPITN). TSA in blood and saliva and CRP levels in blood were significantly increased in CVD patients compared with the control group. CPITN ranged from 2 to 4 in both groups. Significant and positive correlations were found between sTSA and saliva SA levels in patients and controls and between tooth loss and TSA both in blood and saliva. Therefore, TSA in saliva may be a useful marker similar to sTSA in CVD patients. Copyright © 2011 S. Karger AG, Basel.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleSerum and saliva sialic acid in periodontitis patients with and without cardiovascular disease
dc.typeMakale
dc.relation.journalPathophysiology of Haemostasis and Thrombosis
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume37
dc.identifier.startpage67
dc.identifier.endpage71
dc.contributor.firstauthorID190569


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster